• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Pharmaceuticals ETF (NY:XPH)

64.65 +1.02 (+1.60%)
Official Closing Price Updated: 8:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 82,544
Open 63.64
Bid (Size) 61.28 (100)
Ask (Size) 68.68 (100)
Prev. Close 63.63
Today's Range 63.54 - 65.03
52wk Range 46.90 - 74.34
Shares Outstanding 36,002
Dividend Yield 0.26%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Better Pharma ETF: iShares IHE vs. State Street XPH ↗
October 10, 2026
IHE concentrates 23.6% in Eli Lilly and delivers 1.4% yield, while XPH spreads risk across 62 holdings with a lower 0.35% expense ratio. 
Via The Motley Fool
Topics ETFs
News headline image
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma ↗
October 10, 2026
BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their five-year returns diverged significantly. 
Via The Motley Fool
Topics ETFs

Performance

52-Week Range 13.0% below 52-week high
64.65
46.9052W Low 74.3452W High
1 Week 0.6% below 1-week high
62.171W Low 65.031W High

State Street SPDR S&P Pharmaceuticals ETF (XPH) traded between $46.90 and $74.34 over the past 52 weeks and last traded at $64.65, 13.0% below its 52-week high. Over the past week it ranged between $62.17 and $65.03.

Past 12 Months
+1.6%
-4.9%
-3.2%
+14.2%
+17.1%
+36.6%
1W +$0.99
1M -$3.36
3M -$2.17
6M +$8.06
YTD +$9.44
1Y +$17.33

XPH was +36.6% over the past year, +14.2% over six months, +17.1% year to date, +1.6% in the last week.

12 Months vs Market
XPH
+36.6%
DIA
+13.5%
SPY
+19.2%
QQQ
+27.4%
IWM
+17.3%

Over the past 12 months XPH returned +36.6% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.

Volume & Liquidity 0.52× 3-mo avg
Today 82,544 3-mo avg 157.7K
1W
296.8K
1M
226.7K
3M
157.7K
6M
116.0K
YTD
110.3K
1Y
97.5K

XPH most recently traded 82,544 shares against a 3-month average daily volume of 157.7K.

More News

Read More
News headline image
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals ↗
October 04, 2026
Via The Motley Fool
Topics ETFs
Why Did AQST Stock Plunge 40% In Pre-Market Today? ↗
January 09, 2026
Via Stocktwits
News headline image
IXJ vs XPH: Global Healthcare ETF or Pharma Focus? ↗
September 11, 2026
Via The Motley Fool
Topics ETFs
News headline image
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH ↗
September 10, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? ↗
September 10, 2026
Via The Motley Fool
Topics ETFs
News headline image
XPH vs PJP: Which Pharma ETF Offers Better Value ↗
August 17, 2026
Via The Motley Fool
Topics ETFs
News headline image
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH ↗
August 12, 2026
Via The Motley Fool
Topics ETFs Stocks
News headline image
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH? ↗
July 16, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH? ↗
July 08, 2026
Via The Motley Fool
Topics ETFs
News headline image
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners? ↗
July 08, 2026
Via The Motley Fool
Topics ETFs
News headline image
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? ↗
June 04, 2026
Via The Motley Fool
Topics ETFs Stocks
News headline image
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH? ↗
June 04, 2026
Via The Motley Fool
Topics ETFs
News headline image
ESPR Stock Falls After Esperion’s Mixed Q4 — Retail Remains Unfazed, Eyes ‘Massive’ Upcoming Catalysts ↗
March 10, 2026
Via Stocktwits
Topics Intellectual Property
News headline image
Why Did CANF Stock Soar 40% In Pre-Market Today? ↗
March 04, 2026
Via Stocktwits
News headline image
TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗
March 03, 2026
Via Stocktwits
Topics Workforce
News headline image
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development ↗
February 18, 2026
Via Stocktwits
Topics ETFs Government
News headline image
NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results ↗
February 10, 2026
Via Stocktwits
News headline image
Why Did CRMD Stock Crash 28% Today? ↗
January 08, 2026
Via Stocktwits
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
November 12, 2025
Via Benzinga
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
Via Benzinga
Topics ETFs
News headline image
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗
September 29, 2025
Via Benzinga
Topics Government World Trade
News headline image
Pharma Tariffs Back In Spotlight On New Trump Threat ↗
September 26, 2025
Via Investor's Business Daily
Topics ETFs Government World Trade
News headline image
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗
September 08, 2025
Via Benzinga

Frequently Asked Questions

Is State Street SPDR S&P Pharmaceuticals ETF publicly traded?
Yes, State Street SPDR S&P Pharmaceuticals ETF is publicly traded.
What exchange does State Street SPDR S&P Pharmaceuticals ETF trade on?
State Street SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Pharmaceuticals ETF?
The ticker symbol for State Street SPDR S&P Pharmaceuticals ETF is XPH on the New York Stock Exchange
What is the current price of State Street SPDR S&P Pharmaceuticals ETF?
The current price of State Street SPDR S&P Pharmaceuticals ETF is 64.65
When was State Street SPDR S&P Pharmaceuticals ETF last traded?
The last trade of State Street SPDR S&P Pharmaceuticals ETF was at 10/09/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Pharmaceuticals ETF?
The market capitalization of State Street SPDR S&P Pharmaceuticals ETF is 2.33M
How many shares of State Street SPDR S&P Pharmaceuticals ETF are outstanding?
State Street SPDR S&P Pharmaceuticals ETF has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap